Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.
Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications.
Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.
Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
April 2019—LGC Maine Standards has added Cerebrospinal Fluid Total Protein to its Validate Body Fluids kit for laboratory-developed test validation, documentation of linearity, calibration verification, and verification of the reportable range.
April 2019—PMT Scientific, a company that designs morgue, pathology, histology, and vivarium medical equipment, is now operating in Redford, Mich. PMT Scientific focuses on providing custom grossing stations along with a complete array of pathology equipment. Its grossing stations incorporate height-adjustable actuators, high-color-rendering lighting, and durable and easy-to-maintain plumbing fixtures, and can come equipped with air quality monitoring devices.
April 2019—Abbott announced it has received the CE mark for its Alinity m automated molecular diagnostics system and assays. Alinity m features ReadiFlex technology, the company’s proprietary technology for true random access, a universal sample rack, and a time to first result of less than 115 minutes. The system can provide 300 results in about eight hours and can have up to 20 assays onboard at one time.
April 2019—EKF Diagnostics has signed a private label distribution agreement with McKesson Medical-Surgical for the company’s hand-held, reagent-free hemoglobin analyzer, the DiaSpect. The DiaSpect will be sold by McKesson under its own branded line as the McKesson Consult Hb analyzer.
March 2019—Sarstedt has released its next generation of vacuum filtration products. Options include bottle top filters, receiver bottles, and assembled units available in 250 mL, 500 mL, and 1,000 mL. The filters contain wide, 90-mm diameter polyethersulfone membranes with 0.2 µm and 0.45 µm pore sizes; 500 mL filters are also available with a 0.1 µm pore size for mycoplasma removal. The bottle tops are one-piece construction to prevent leakage above the neck and reduce overall height.
March 2019—Fluidigm introduced its Maxpar Human Immune Monitoring Panel Kit for comprehensive immune cell profiling in cancer and immune-mediated diseases. The immune monitoring kit contains 29 metal-labeled antibodies and reagents designed for deep immune profiling of human peripheral blood mononuclear cells in one tube.
March 2019—BD announced FDA 510(k) clearance of its BD Max enteric viral panel, a molecular diagnostic test for the direct qualitative detection and differentiation of enteric viral pathogens that cause viral gastroenteritis.
March 2019—Bio-Techne announced the launch of its cell and gene therapy portfolio.
March 2019—BD announced that its BD Phoenix CPO detect test to identify infections caused by carbapenemase-producing organisms has received 510(k) clearance by the Food and Drug Administration.
March 2019—BioMérieux’s BacT/Alert BPA and BPN culture bottles have received 510(k) clearance from the FDA. The culture bottles are for quality control testing of leukocyte-reduced apheresis platelet units and support the growth of aerobic and anaerobic microorganisms in two types of leukocyte-reduced units: apheresis platelet units and both single and pools of up to six units of whole blood platelet concentrates.
